Yachi A, Akahonai Y, Takahashi A, Wada T
Ann N Y Acad Sci. 1975 Aug 22;259:435-45. doi: 10.1111/j.1749-6632.1975.tb25441.x.
Incidences of alpha2H were investigated in sera from patients with various malignant and nonmalignant diseases. With counterimmunoelectrophoresis, alpha2H was detected in a wide variety of neoplastic diseases, and also in nonmalignant hematological disorders. Diagnostic significance was described regarding primary hepatoma and acute myelogenous leukemia. Factors affecting alpha2H levels in sera were also discussed in relation to the neoplastic and nonneoplastic disease process.
研究了各种恶性和非恶性疾病患者血清中α2H的发生率。通过对流免疫电泳法,在多种肿瘤性疾病以及非恶性血液系统疾病中均检测到了α2H。阐述了其对原发性肝癌和急性髓细胞白血病的诊断意义。还讨论了血清中α2H水平的影响因素与肿瘤性和非肿瘤性疾病进程的关系。